Financial Ratios

ELDER HEALTH CARE LTD.

NSE : NABSE : 524830ISIN CODE : INE950E01010Industry : Pharmaceuticals & DrugsHouse : Elder
BSE8.550 (0 %)
PREV CLOSE ( ) 8.55
OPEN PRICE ( ) 8.55
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2060
TODAY'S LOW / HIGH ( )8.55 8.55
52 WK LOW / HIGH ( ) 8.558.55
NSE
This Company is not listed in NSE
Select year
ParticularsJun2014Jun2013Mar2012Mar2011Mar2010
Operational & Financial Ratios
   Earnings Per Share (Rs)-84.023.9911.184.220.12
   CEPS(Rs)-81.706.8413.426.402.27
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)-53.0830.9526.9515.7710.38
   Tax Rate(%)-4.040.53-2.2327.2829.72
Margin Ratios
   Core EBITDA Margin(%)-5.656.938.416.072.98
   EBIT Margin(%)-33.106.558.236.113.82
   Pre Tax Margin(%)-45.200.852.832.000.09
   PAT Margin (%)-47.020.852.891.460.06
   Cash Profit Margin (%)-45.721.453.472.211.12
Performance Ratios
   ROA(%)-38.861.544.802.640.09
   ROE(%)0.0013.8052.3632.311.29
   ROCE(%)-47.3317.2020.1917.0610.88
   Asset Turnover(x)0.831.811.661.811.49
   Sales/Fixed Asset(x)3.699.808.196.224.39
   Working Capital/Sales(x)-2.25333.36-36.7015.705.99
Efficiency Ratios
   Fixed Capital/Sales(x)0.270.100.120.160.23
   Receivable days250.92112.71101.9556.8148.16
   Inventory Days76.7742.2155.0652.2548.67
   Payable days166.6560.4790.2391.74118.75
Valuation Parameters
   PER(x)0.0010.268.4918.43682.07
   PCE(x)-1.066.007.0812.1637.40
   Price/Book(x)-1.631.323.524.948.17
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)1.280.370.690.630.80
   EV/Core EBITDA(x)-24.005.077.718.9516.25
   EV/EBIT(x)-3.825.548.2510.0520.76
   EV/CE(x)1.150.730.920.981.16
   M Cap / Sales0.490.090.250.270.42
Growth Ratio
   Net Sales Growth(%)-62.1022.0434.4641.5958.02
   Core EBITDA Growth(%)-127.90-1.1071.31101.2866.79
   EBIT Growth(%)-291.57-3.0779.71128.9287.49
   PAT Growth(%)-2203.24-64.28164.723296.27108.93
   EPS Growth(%)-2203.24-64.28164.723296.14108.93
Financial Stability Ratios
   Total Debt/Equity(x)-2.644.266.296.567.53
   Current Ratio(x)0.661.010.961.171.74
   Quick Ratio(x)0.520.780.680.711.05
   Interest Cover(x)-2.741.151.521.491.02
   Total Debt/Mcap(x)1.623.211.781.330.92

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.